Company / Operating Income per Share
Century Therapeutics, Inc. Operating Income per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.61
FY2025
5-year range
-$2.43 / -$1.61
FY2022-FY2025
Trend
+33.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-2.43 to $-1.61 over the past 2 years.
Based on SEC 10-K filings.
-1.61 in FY2025.
Improved from $-2.43 to $-1.61 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 33.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.61 | +33.7% |
| FY2024 | -$2.43 | +0.2% |
| FY2023 | -$2.43 | -49.9% |
| FY2022 | -$1.62 | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026